Selling into a wave of new capacity being built by others: management describes its customers' own build-out spending as
The model's full reasoning — Q3 2018 call → NOWe need to determine if management explains current momentum and near-term trajectory chiefly by pointing to a wave of new building/equipping/capacity-creation by other parties, for which the company already supplies part, and that this build-out is early/intensifying. Let's analyze the transcript. The company is Alkermes, a pharmaceutical company. They discuss VIVITROL, ARISTADA, ALKS 5461, ALKS 3831, BIIB098, ALKS 4230. The context is not about physical infrastructure building. They talk about policy, legislation, treatment systems, etc. Key points: For VIVITROL, they mention the opioid epidemic, legislation like the Support for Patients and Communities Act, which provides funding for comprehensive opioid recovery centers, and state collaborative response grants. They say "This is an opportunity to establish centers of excellence" and "the federal legislation also extends funding for state collaborative response grants for an additional three years with $500 million to be distributed annually between 2019 and 2021, ensuring consistent availability of funding will be key as long-term investments are made in building new treatment infrastructure and programs." So they are talking about building new treatment infrastructure. But is that the company's customers? The company supplies VIVITROL, a medication. The "build-out" is of treatment centers and programs. The company already supplies VIVITROL to these centers. They say "We continue to collaborate with the federal, state and local policymakers to expand the availability of treatment." And they see growth in VIVITROL. But is this a wave of building? They mention "comprehensive opioid recovery centers" which are new facilities. They also mention "state collaborative response grants" which fund programs. They say "long-term investments are made in building new treatment infrastructure and programs." So there is a build-out of treatment capacity. The company is already in it because VIVITROL sales are growing. And they say it's early? They say "many of the initiatives are being implemented today across the country will serve as a foundation for increased utilization of VIVITROL over the long-term." So they see it as early and long-term. But is this the chief explanation for momentum? They also discuss ARISTADA, which is their own product launch, and other pipeline.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| RDCM | RADCOM Ltd. | Q4 2023 | 2024-01-31 | A |
| TEL | TE Connectivity Ltd. | Q4 2023 | 2023-11-01 | B |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| IPGP | IPG Photonics Corporation | Q3 2021 | 2021-11-02 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
TEL · Q4 2023 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building or capacity-creation by others, that's early or intensif...YES The transcript shows management framing the company's momentum chiefly through a wave of external capacity creation: EV production growth (40% in 2023, expected continued growth next year, with Asia as driver), renewable energy adoption (wind/solar), and AI/cloud applications. They describe others (OEMs, installers 3rd parties) building new productive capability—new EV platforms, renewable sites, AI clusters—while TE already supplies into it via content outperformance and early ramps. Current business is real (sequential order growth, $1.3B pipeline, $100M+ incremental AI revenue). The wave is early/intensifying 2024–2025 (3–4 year programs, more phases ahead, destocking normalizing). This is presented as the primary secular driver offsetting cyclical weakness, not just consumption or pricing. Other elements (destocking, FX) are secondary. Thus all three conditions are met in substance.
ATI · Q1 2018 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building or capacity-creation by other parties, like customers, t...YES The transcript shows management attributing HPMC momentum chiefly to the "ongoing production ramp of next-generation jet engines at all of our major engine OEM customers" and the "industry is currently in the early phases of a multi-year production expansion." This describes OEMs creating new productive capacity through rate ramps and build growth for next generation engines. Management confirms current business from this wave with "next-generation product sales reached 48% of total jet engine product sales" and "65% increase in next-generation product sales," plus "seventh consecutive quarter of year-over-year margin expansion.
RDCM · Q4 2023 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building, equipping, or capacity-creation by other parties (custo...YES The transcript shows management framing 2024 momentum around operators’ ongoing 5G standalone network build-outs (new productive capacity being created by customers), with RADCOM already supplying assurance software to those projects and the wave described as still early and accelerating. All three conditions are met in Eyal Harari’s prepared remarks and Q&A.